Literature DB >> 9833810

Normoxic wound fluid contains high levels of vascular endothelial growth factor.

T R Howdieshell1, C Riegner, V Gupta, D Callaway, K Grembowicz, P L McNeil.   

Abstract

OBJECTIVE: To examine the temporal integration of vascular endothelial growth factor (VEGF), which has been shown to be present in wound fluid, with the putatively related processes of wound fluid oxygen content, wound angiogenesis, and granulation tissue formation. SUMMARY BACKGROUND DATA: During cutaneous wound repair, new tissue formation starts with reepithelialization and is followed by granulation tissue formation, including neutrophil and macrophage accumulation, fibroblast ingrowth, matrix deposition, and angiogenesis. Because angiogenesis and increased vascular permeability are characteristic features of wound healing, VEGF may play an important role in tissue repair.
METHODS: A ventral hernia, surgically created in the abdominal wall of female swine, was repaired using silicone sheeting and skin closure. Over time, a fluid-filled wound compartment formed, bounded by subcutaneous tissue and omentum. Ultrasonography was performed serially to examine the anatomy and dimensions of the subcutaneous tissue and wound compartment. Serial wound fluid samples, obtained by percutaneous aspiration, were analyzed for PO2, PCO2, pH, and growth factor concentrations.
RESULTS: Three independent assays demonstrate that VEGF protein is present at substantially elevated levels in a wound fluid associated with the formation of abdominal granulation tissue. However, the wound fluid is not hypoxic at any time. Serial sampling reveals that transforming growth factor beta-1 protein appears in the wound fluid before VEGF.
CONCLUSIONS: The results suggest that VEGF is a prominent regulator of wound angiogenesis and vessel permeability. A factor other than hypoxia, perhaps the earlier appearance of another growth factor, transforming growth factor beta-1, may positively regulate VEGF appearance in the wound fluid.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9833810      PMCID: PMC1191577          DOI: 10.1097/00000658-199811000-00011

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  31 in total

Review 1.  Endothelial cell regulation by transforming growth factor-beta.

Authors:  A RayChaudhury; P A D'Amore
Journal:  J Cell Biochem       Date:  1991-11       Impact factor: 4.429

2.  Conditioned medium from mouse sarcoma 180 cells contains vascular endothelial growth factor.

Authors:  R A Rosenthal; J F Megyesi; W J Henzel; N Ferrara; J Folkman
Journal:  Growth Factors       Date:  1990       Impact factor: 2.511

3.  Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor.

Authors:  R G Tilton; T Kawamura; K C Chang; Y Ido; R J Bjercke; C C Stephan; T A Brock; J R Williamson
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

Review 4.  The vascular endothelial growth factor family of polypeptides.

Authors:  N Ferrara; K A Houck; L B Jakeman; J Winer; D W Leung
Journal:  J Cell Biochem       Date:  1991-11       Impact factor: 4.429

5.  The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA.

Authors:  K A Houck; N Ferrara; J Winer; G Cachianes; B Li; D W Leung
Journal:  Mol Endocrinol       Date:  1991-12

6.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis.

Authors:  D Shweiki; A Itin; D Soffer; E Keshet
Journal:  Nature       Date:  1992-10-29       Impact factor: 49.962

7.  Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.

Authors:  K H Plate; G Breier; H A Weich; W Risau
Journal:  Nature       Date:  1992-10-29       Impact factor: 49.962

8.  A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines.

Authors:  D R Senger; C A Perruzzi; J Feder; H F Dvorak
Journal:  Cancer Res       Date:  1986-11       Impact factor: 12.701

9.  Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture.

Authors:  Y Sato; D B Rifkin
Journal:  J Cell Biol       Date:  1989-07       Impact factor: 10.539

10.  Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing.

Authors:  L F Brown; K T Yeo; B Berse; T K Yeo; D R Senger; H F Dvorak; L van de Water
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

View more
  10 in total

Review 1.  What do we mean by the term "inflammation"? A contemporary basic science update for sports medicine.

Authors:  A Scott; K M Khan; C R Roberts; J L Cook; V Duronio
Journal:  Br J Sports Med       Date:  2004-06       Impact factor: 13.800

2.  Early wound healing exhibits cytokine surge without evidence of hypoxia.

Authors:  Z A Haroon; J A Raleigh; C S Greenberg; M W Dewhirst
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

3.  [Effects of Shenggu injection on mRNA expression of vascular endothelia growth factor in rat osteoblasts in vitro].

Authors:  Jie Cheng; Rui Peng; Yuan Yu; Yong-qing Wang; Yang Zou; Ren-yun Xia
Journal:  Chin J Integr Med       Date:  2005-09       Impact factor: 1.978

4.  Regulating VEGF signaling in platelet concentrates via specific VEGF sequestering.

Authors:  David G Belair; Ngoc Nhi Le; William L Murphy
Journal:  Biomater Sci       Date:  2016-03-24       Impact factor: 6.843

5.  3D Printed Multiplexed Competitive Migration Assays with Spatially Programmable Release Sources.

Authors:  Alexander P Haring; Emily G Thompson; Raymundo D Hernandez; Sahil Laheri; Megan E Harrigan; Taylor Lear; Harald Sontheimer; Blake N Johnson
Journal:  Adv Biosyst       Date:  2019-12-05

6.  Specific VEGF sequestering to biomaterials: influence of serum stability.

Authors:  David G Belair; William L Murphy
Journal:  Acta Biomater       Date:  2013-06-29       Impact factor: 8.947

7.  Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells.

Authors:  Robert D Galiano; Oren M Tepper; Catherine R Pelo; Kirit A Bhatt; Matthew Callaghan; Nicholas Bastidas; Stuart Bunting; Hope G Steinmetz; Geoffrey C Gurtner
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

8.  The effect of intravitreal anti-VEGF agents on peripheral wound healing in a rabbit model.

Authors:  John Christoforidis; Robert Ricketts; Cedric Pratt; Jordan Pierce; Scott Bean; Michael Wells; Xiaoli Zhang; Krista La Perle
Journal:  Clin Ophthalmol       Date:  2012-01-10

9.  The effect of intravitreal bevacizumab and ranibizumab on cutaneous tensile strength during wound healing.

Authors:  John B Christoforidis; Jillian Wang; Angela Jiang; James Willard; Cedric Pratt; Mahmoud Abdel-Rasoul; Sashwati Roy; Heather Powell
Journal:  Clin Ophthalmol       Date:  2013-01-24

10.  Serum-dependence of affinity-mediated VEGF release from biomimetic microspheres.

Authors:  David G Belair; Andrew S Khalil; Michael J Miller; William L Murphy
Journal:  Biomacromolecules       Date:  2014-05-12       Impact factor: 6.988

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.